Establishment Labs [ESTA] vs Abbott Laboratories [ABT] Detailed Stock Comparison

Establishment Labs Holdings Inc.

NASDAQ
Loading...

Abbott Laboratories

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Establishment Labs Holdings Inc. wins in 2 metrics, Abbott Laboratories wins in 16 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Establishment Labs Holdings Inc. Abbott Laboratories Better
P/E Ratio (TTM) -37.89 25.97 Abbott Laboratories
Price-to-Book Ratio 79.68 3.09 Abbott Laboratories
Debt-to-Equity Ratio 1,123.15 26.79 Abbott Laboratories
PEG Ratio 0.41 -1.41 Establishment Labs Holdings Inc.
EV/EBITDA -70.21 13.74 Abbott Laboratories
Profit Margin (TTM) -24.19% 13.90% Abbott Laboratories
Operating Margin (TTM) -6.08% 16.50% Abbott Laboratories
EBITDA Margin (TTM) N/A 16.50% N/A
Return on Equity -133.25% 12.36% Abbott Laboratories
Return on Assets (TTM) -6.93% 7.52% Abbott Laboratories
Free Cash Flow (TTM) $-57.61M $7.40B Abbott Laboratories
Dividend Yield N/A 1.97% N/A
1-Year Return 119.39% -34.98% Establishment Labs Holdings Inc.
Price-to-Sales Ratio (TTM) 8.92 3.57 Abbott Laboratories
Enterprise Value $2.07B $166.96B Abbott Laboratories
EV/Revenue Ratio 9.79 3.70 Abbott Laboratories
Gross Profit Margin (TTM) 70.46% N/A N/A
Revenue per Share (TTM) $7 $26 Abbott Laboratories
Earnings per Share (Diluted) $-1.72 $3.57 Abbott Laboratories
Beta (Stock Volatility) 1.08 0.78 Abbott Laboratories
Short % of Float 22.26% 1.53% Abbott Laboratories

Establishment Labs Holdings Inc. vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

ESTA
ABT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Establishment Labs Holdings Inc.2.52%12.52%28.06%32.66%16.91%22.33%
Abbott Laboratories0.56%-2.02%4.97%-19.35%-30.98%-28.60%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Establishment Labs Holdings Inc.119.39%25.90%5.07%211.25%211.25%211.25%
Abbott Laboratories-34.98%-16.97%-20.08%135.84%255.56%329.52%

Performance & Financial Health Analysis: Establishment Labs Holdings Inc. vs Abbott Laboratories

MetricESTAABT
Market Information
Market Cap i$1.91B$160.70B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i451,43713,495,583
90 Day Avg. Volume i478,30912,934,461
Last Close$84.21$88.67
52 Week Range$33.35 - $86.00$81.97 - $139.06
% from 52W High-2.08%-36.24%
All-Time High$93.80 (Apr 18, 2022)$142.60 (Dec 27, 2021)
% from All-Time High-10.22%-37.82%
Growth Metrics
Quarterly Revenue Growth0.45%0.08%
Quarterly Earnings Growth0.45%-0.19%
Financial Health
Profit Margin (TTM) i-0.24%0.14%
Operating Margin (TTM) i-0.06%0.17%
Return on Equity (TTM) i-1.33%0.12%
Debt to Equity (MRQ) i1,123.1526.79
Cash & Liquidity
Book Value per Share (MRQ)$0.80$30.02
Cash per Share (MRQ)$2.58$5.14
Operating Cash Flow (TTM) i$-50,890,000$10.80B
Levered Free Cash Flow (TTM) i$-41,574,000$13.77B
Dividends
Last 12-Month Dividend Yield iN/A1.97%
Last 12-Month Dividend iN/A$2.40

Valuation & Enterprise Metrics Analysis: Establishment Labs Holdings Inc. vs Abbott Laboratories

MetricESTA (Apr 24, 2026)ABT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-37.8925.97
Forward P/E i316.3515.29
PEG Ratio i0.41-1.41
Price to Sales (TTM) i8.923.57
Price to Book (MRQ) i79.683.09
Market Capitalization
Market Capitalization i$1.91B$160.70B
Enterprise Value i$2.07B$166.96B
Enterprise Value Metrics
Enterprise to Revenue i9.793.70
Enterprise to EBITDA i-70.2113.74
Risk & Other Metrics
Beta i1.080.78
Book Value per Share (MRQ) i$0.80$30.02

Financial Statements Comparison: Establishment Labs Holdings Inc. vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricESTA (2025)ABT (2025)
Revenue/Sales i211.08M44.33B
Cost of Goods Sold i64.77M19.32B
COGS % of Revenue i30.7%43.6%
Gross Profit i146.31M25.01B
Gross Margin i69.3%56.4%
Research & Development i20.25M2.94B
Operating Income (EBIT) i-39.01M8.05B
Operating Margin i-18.5%18.2%
EBITDA i-22.29M12.03B
EBITDA Margin i-10.6%27.1%
Pre-Tax Income i-58.02M8.47B
Pre-Tax Income % of Revenue i-27.5%19.1%
Income Tax i-6.96M1.94B
Income Tax % of Revenue i-3.3%4.4%
Net Income (Profit) i-51.06M6.52B
Profit Margin i-24.2%14.7%

Balance Sheet & Liquidity Metrics

MetricESTA (2025)ABT (2025)
Cash & Equivalents i75.57M8.52B
Total Current Assets i249.94M26.00B
Total Current Assets % of Revenue i118.4%58.6%
Total Current Liabilities i82.14M16.50B
Total Current Liabilities % of Revenue i38.9%37.2%
Long-Term Debt i250.34M10.83B
Long-Term Debt % of Revenue i118.6%24.4%
Total Shareholders Equity i23.55M52.77B
Retained Earnings i-495.76M49.78B
Retained Earnings % of Revenue i-234.9%112.3%
Property, Plant & Equipment i4.34M17.57B

Cash Flow Statement Comparison

MetricESTA (2025)ABT (2025)
Operating Cash Flow i-50.78M10.80B
Operating Cash Flow % of Revenue i-24.1%24.4%
Capital Expenditures i-6.05M-2.17B
Free Cash Flow i-57.61M7.40B
FCF Margin i-27.3%16.7%
Debt Repayment i-1.02M-1.50B
Common Stock Repurchase iN/A-893.00M

Short Interest & Institutional Ownership Analysis

MetricESTAABT
Shares Short i5.22M23.83M
Short Ratio i9.901.93
Short % of Float i22.26%1.53%
Shares Outstanding i29.30M1.74B
Float Shares i19.22M1.73B
% Held by Insiders i10.16%0.54%
% Held by Institutions i102.08%82.23%
% Held by Public i-12.24%17.23%

Dividend Analysis & Yield Comparison: Establishment Labs Holdings Inc. vs Abbott Laboratories

MetricESTAABT
Last 12-Month Dividend iN/A$2.40
Last 12-Month Dividend Yield iN/A1.97%
3-Year Avg Annual Dividend iN/A$2.24
3-Year Avg Dividend Yield iN/A0.50%
3-Year Total Dividends iN/A$6.72
Ex-Dividend DateN/AJan 15, 2026